BUIJNSTERS, PETRUS JACOBUS JOHANNES ANTONIUS,GIJSEN, HENRICUS JACOBUS MARIA,DRINKENBURG, WILHELMUS HELENA IGNATIUS MARIA,AHNAOU, ABDALLAH
申请号：
CA3001768
公开号：
CA3001768A1
申请日:
2016.11.02
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to a novel [l,2,4]triazolo[l,5-a]pyrimidin-yl derivative of formula (1) as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
